trending Market Intelligence /marketintelligence/en/news-insights/trending/kHjGXtSyu68gcoalp_j4gg2 content esgSubNav
In This List

Ascendis Pharma closes ADS offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Ascendis Pharma closes ADS offering

Ascendis Pharma A/S closed an underwritten public offering of 3.8 million American depositary shares for net proceeds of about $126.1 million.

The company priced the ADSs, each of which represents 1 ordinary share, at $35.50 apiece.

Underwriters also received a 30-day option to buy up to an additional 570,000 ADSs.

Underwriters were J.P. Morgan Securities LLC, Merrill Lynch, Pierce Fenner & Smith Inc., Credit Suisse Securities (USA) LLC, Wells Fargo Securities LLC and Wedbush Securities Inc.